Long-Covid in Patients Post Rehabilitation Treatment and Reintegration Into Everyday Life

March 3, 2023 updated by: Rehazentrum Walenstadtberg

Occurrence of Long-Covid in Patients After Inpatient Rehabilitation Due to Acute Covid-19 Infection. How Easy is it for Patients to Return to Everyday Life and Work After Inpatient Rehabilitation Due to Acute Covid-19-infection?

The aim of the first study is to investigate how often a long Covid syndrome occurs after an inpatient rehabilitation due to previous hospitalization because of after acute Covid and whether there might be a connection with the severity during acute illness. 3 clusters of acute cases have been identified to be studied with regard to the long-term symptoms

  1. Mild course (medication, oxygen)
  2. Moderate course (IPS-IMC with NIV but without intubation)
  3. Severe course (intubation)

The aim of the second study is to use a catamnestic survey and subsequent evaluation of the information to gain an insight into the existing functional deficits relevant to everyday life and restriction of the ability to participate in the workplace after rehabilitation treatment. The assessment of functional deficits is carried out in relation to:

  1. Deficits in everyday skills (ADLs)
  2. Restrictions in the ability to participate in the profession.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

All patients who had been infected with Walenstadtberg after acute Covid infection were included.

Patients were hospitalized for inpatient rehabilitation in the period from 01.04.2020 to 30.06.2022.

A written follow-up survey was carried out with regard to a possible persistent long Covid symptoms and possible persistent deficits in everyday skills and Restrictions in the ability to participate in the profession. There are 2 cohort studies.

Study Type

Observational

Enrollment (Anticipated)

500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Men and Women over 18 years of age who have been treated at Rehazentrum Walenstadtberg after being hospitilized primarily because of an acute Covid-19 infection

Description

Inclusion Criteria:

  • >18 years of age
  • treated at a rehabilitation facility after being hospitilized for covid-19 infection
  • complete questionnaire
  • written consent to use collected data

Exclusion Criteria:

  • < 18 years
  • incomplete questionnaire

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Occurance of Symptoms pointing at Long-Covid after rehabilitation treatment
Time Frame: 2 years
Occurance of Symptoms pointing at Long-Covid after rehabilitation treatment
2 years
Occurance of deficits in managing everyday life and work after covid infection
Time Frame: 2 years
Investigation of deficits experienced by patients who have been treated at a rehabilitation facility after beeing hospitilized for a covid-19 infection and the impact of these deficits in everday life as well as in the workplace
2 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
reinfection with covid-19 after rehabilition treatment
Time Frame: 2 years
reinfection with covid-19 after rehabilition treatment
2 years
Impact of Covid-19 infection on quality of life
Time Frame: 2 years
Impact of Covid-19 infection on quality of life in patients who have been treated at a rehabilition facility after beeing hospitilized due to a covid-19 infection
2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Rehazentrum Walenstadtberg

Investigators

  • Study Director: Stefan Bachman, Prof., Rehazentrum Walenstadtberg

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

March 20, 2023

Primary Completion (Anticipated)

September 1, 2023

Study Completion (Anticipated)

November 1, 2023

Study Registration Dates

First Submitted

March 1, 2023

First Submitted That Met QC Criteria

March 3, 2023

First Posted (Estimate)

March 6, 2023

Study Record Updates

Last Update Posted (Estimate)

March 6, 2023

Last Update Submitted That Met QC Criteria

March 3, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • Covid Outcome

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Long COVID

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Montenegro

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe